Skip to Main Content

Paper Details

Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs.
Clin Exp Med
2
2023
AMO1, KMS20, MM, MM cells, Multiple myeloma, RPMI8226, RPMI8226 cells, apoptotic cells, bortezomib, cancer of, doxorubicin, human, human MM cell lines, human multiple myeloma cells, multiple myeloma, patients, primary multiple myeloma, primary multiple myeloma cells, sensitive cells, terminally differentiated plasma cells
Author NameAffiliation
Kenneth C AndersonLeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute
Kenneth C AndersonLeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute
  • 1 - 2

Datasets

Release 1.2